We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
-4.12%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$6.57B
AUM Growth
-$731M
Cap. Flow
-$225M
Cap. Flow %
-3.42%
Top 10 Hldgs %
32.2%
Holding
361
New
20
Increased
74
Reduced
159
Closed
103

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$76.5M
2
DDOG icon
Datadog
DDOG
+$70.6M
3
PI icon
Impinj
PI
+$64.7M
4
AVID
Avid Technology Inc
AVID
+$24.3M
5
DOCU
DocuSign
DOCU
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 32.7%
2 Consumer Discretionary 19.91%
3 Healthcare 15.72%
4 Communication Services 11.32%
5 Industrials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HWM icon
226
Howmet Aerospace
HWM
$90.1B
$534K 0.01%
+11,539
New +$562K
PATH icon
227
UiPath
PATH
$7.45B
$523K 0.01%
30,562
-291
-0.9% -$4.85K
COHR icon
228
Coherent
COHR
$54.3B
$512K 0.01%
15,694
-66
-0.4% -$2.71K
CLFD icon
229
Clearfield
CLFD
$394M
$502K 0.01%
17,515
-32
-0.2% -$1.26K
LPLA icon
230
LPL Financial
LPLA
$26.8B
$433K 0.01%
1,820
+297
+20% +$69K
DASH icon
231
DoorDash
DASH
$87.1B
$422K 0.01%
5,309
+528
+11% +$43K
PRTS icon
232
CarParts.com
PRTS
$67.3M
$413K 0.01%
10,033
-39
-0.4% -$1.73K
SNAP icon
233
Snap
SNAP
$9.94B
$393K 0.01%
44,122
+250
+0.6% +$2.61K
RCKT icon
234
Rocket Pharmaceuticals
RCKT
$358M
$387K 0.01%
18,904
-4,484
-19% -$81.5K
ENFN
235
DELISTED
Enfusion, Inc.
ENFN
$382K 0.01%
42,577
+1,157
+3% +$11K
VITL icon
236
Vital Farms
VITL
$424M
$374K 0.01%
32,305
-639
-2% -$7.36K
CHWY icon
237
Chewy
CHWY
$8.59B
$362K 0.01%
19,811
RARE icon
238
Ultragenyx Pharmaceutical
RARE
$1.31B
$342K 0.01%
9,592
-56
-0.6% -$2.22K
VISN
239
Vistance Networks Inc
VISN
$1.54B
$339K 0.01%
100,761
-999,440
-91% -$4.09M
GRND icon
240
Grindr
GRND
$2.64B
$337K 0.01%
58,562
+4,603
+9% +$25.7K
LLYVK icon
241
Liberty Live Group Series C
LLYVK
$8.98B
$327K 0.01%
+10,196
New +$338K
SHEN icon
242
Shenandoah Telecom
SHEN
$641M
$326K 0.01%
15,817
+450
+3% +$9.22K
SILK
243
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$298K ﹤0.01%
19,882
+5,056
+34% +$105K
EB
244
DELISTED
Eventbrite
EB
$289K ﹤0.01%
29,301
ZLAB icon
245
Zai Lab
ZLAB
$2.79B
$246K ﹤0.01%
10,138
-90,499
-90% -$2.41M
STOK icon
246
Stoke Therapeutics
STOK
$1.81B
$245K ﹤0.01%
62,259
+11,185
+22% +$73.5K
VZLA
247
Vizsla Silver
VZLA
$1.31B
$238K ﹤0.01%
229,274
-2,311
-1% -$2.53K
TDW icon
248
Tidewater
TDW
$4.46B
$232K ﹤0.01%
3,266
+448
+16% +$28.3K
L icon
249
Loews
L
$22.3B
$228K ﹤0.01%
3,603
+98
+3% +$6.11K
CAVA icon
250
CAVA Group
CAVA
$6.08B
$211K ﹤0.01%
6,875
-625
-8% -$27.3K

Similar funds

Gilder Gagnon Howe & Co's Q3 2023 Portfolio in Review

As of Q3 2023, Gilder Gagnon Howe & Co held 361 positions worth $6.57B, down 10% from $7.31B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $225M in Q3 2023, closing 103 positions and reducing 159 holdings. Its most notable exit was Avid Technology Inc, an estimated $24.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Knife River worth $37.9M.

  • Gilder Gagnon Howe & Co's largest Q3 2023 buy was Knife River: 777,114 shares worth $37.9M.
  • Gilder Gagnon Howe & Co added most to Intel in Q3 2023, an estimated $72M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2023 reduction was Tesla, cutting an estimated $76.5M.
  • Gilder Gagnon Howe & Co fully exited Avid Technology Inc in Q3 2023, selling an estimated $24.3M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 32% of its $6.57B portfolio in Q3 2023.
  • Gilder Gagnon Howe & Co opened 20 new positions and closed 103 in Q3 2023.
  • Gilder Gagnon Howe & Co's portfolio value fell 10% quarter-over-quarter to $6.57B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2023, filed 14 Nov 2023.